sickle cell anemia - Nursing Case Study

Pathophysiology

• Primary mechanism: Sickle cell anemia is caused by a genetic mutation in the HBB gene, leading to the production of abnormal hemoglobin S (HbS). When deoxygenated, HbS polymerizes, causing red blood cells to become rigid and sickle-shaped.

• Secondary mechanism: These sickle-shaped cells are prone to hemolysis and have a shorter lifespan, leading to chronic hemolytic anemia. Their rigidity also results in vaso-occlusion, where sickled cells obstruct blood flow in small vessels, causing ischemia and pain.

• Key complication: Vaso-occlusion can lead to acute pain episodes known as sickle cell crises, as well as long-term organ damage due to repeated ischemic events, significantly impacting patient quality of life and requiring ongoing management.

Patient Profile

Demographics:

35-year-old female, school teacher

History:

• Key past medical history: Diagnosed with sickle cell anemia at age 5, history of vaso-occlusive crises, splenectomy performed at age 10

• Current medications: Hydroxyurea, folic acid supplements, acetaminophen as needed for pain

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing frequency of painful episodes in the past month

• Key symptoms: Fatigue, joint pain, shortness of breath, mild jaundice

• Vital signs: Temperature 100.2°F, heart rate 102 bpm, respiratory rate 24 breaths/min, blood pressure 110/70 mmHg

Section 1

In the initial assessment, the 35-year-old female patient presents with increasing fatigue and joint pain, which are indicative of a possible exacerbation of her sickle cell anemia. A thorough physical examination reveals mild scleral icterus, suggesting ongoing hemolysis, and tenderness in the joints, particularly in the knees and elbows. These findings align with her reported increase in painful episodes. Auscultation of the lungs reveals clear breath sounds, yet her respiratory rate is elevated at 24 breaths per minute, which could indicate compensatory mechanisms for anemia or pain. Her heart rate is tachycardic at 102 bpm, possibly a response to anemia or pain as well.

Laboratory results further define the clinical picture. A complete blood count shows hemoglobin levels at 7.8 g/dL, significantly lower than normal, confirming the presence of chronic hemolytic anemia. Reticulocyte count is elevated, reflecting the bone marrow's response to anemia. Lactate dehydrogenase and indirect bilirubin levels are also increased, consistent with ongoing hemolysis. A peripheral blood smear reveals numerous sickle-shaped red blood cells. These findings suggest that the increasing frequency of vaso-occlusive crises may be linked to either suboptimal management of her sickle cell disease or new stressors that exacerbate her condition.

As the patient discusses her recent history, she mentions increased stress due to her workload as a school teacher and recent exposure to cooler temperatures, both of which could contribute to the frequency of her crises. This information prompts consideration of potential adjustments in her management plan, including optimizing her current medication regimen and exploring additional supportive measures such as pain management strategies and lifestyle modifications to reduce stress. The healthcare team must now deliberate on the most effective interventions to prevent further complications and improve her quality of life.

Section 2

In the days following her initial assessment, the patient experiences a noticeable change in her status. She presents to the clinic with increased shortness of breath and a persistent cough. Despite clear breath sounds on auscultation previously, her current respiratory assessment reveals scattered bilateral crackles, suggesting a possible acute chest syndrome, a known complication of sickle cell disease. Her respiratory rate has increased to 28 breaths per minute, and her oxygen saturation has dropped to 88% on room air, further supporting this suspicion. Her heart rate has increased to 112 bpm, exacerbating her previous tachycardia.

Additional diagnostic tests are conducted to confirm this new complication. A chest X-ray reveals infiltrates in the lower lobes of the lungs, indicative of acute chest syndrome. Arterial blood gas analysis shows a pH of 7.35, PaO2 of 55 mmHg, and PaCO2 of 32 mmHg, confirming hypoxemia and respiratory alkalosis, likely secondary to hyperventilation. Her white blood cell count has increased to 15,000/mm³, which could denote an inflammatory response or infection, although no fever is noted at present.

The healthcare team must now consider a multifaceted approach to manage the acute chest syndrome and prevent further deterioration. This includes initiating supplemental oxygen therapy to improve her oxygen saturation and considering the use of broad-spectrum antibiotics to address any underlying infection. Further, the team contemplates the addition of a bronchodilator to help alleviate respiratory symptoms and the potential need for red blood cell transfusion to reduce the proportion of sickled cells and improve her hemoglobin levels. These interventions aim to stabilize her respiratory function and address the acute complication while continuing to explore strategies for long-term management and prevention of future crises.

Section 3

The initial interventions aimed at managing the patient's acute chest syndrome are promptly initiated. The patient is placed on supplemental oxygen via nasal cannula, which improves her oxygen saturation to 94%. Despite this improvement, her respiratory rate remains elevated at 26 breaths per minute, indicating persistent respiratory distress. The healthcare team decides to administer a bronchodilator, which provides some relief, reducing her respiratory rate to 22 breaths per minute. However, the patient continues to report dyspnea and fatigue, suggesting that further interventions may be needed.

Following the implementation of broad-spectrum antibiotics, the patient's white blood cell count begins to stabilize, decreasing to 12,000/mm³ over the next 48 hours. This indicates a potential response to the treatment, addressing any underlying infection that may have contributed to her condition. However, her hemoglobin level remains low at 7.5 g/dL, and a decision is made to proceed with a red blood cell transfusion. This intervention aims to decrease the proportion of sickled cells in her circulation, potentially improving oxygen delivery and reducing the risk of further complications.

Within 24 hours of the transfusion, there is a noticeable improvement in the patient's overall status. Her heart rate decreases to 98 bpm, and she reports feeling less fatigued. Her repeat arterial blood gas analysis shows a pH of 7.38, PaO2 of 65 mmHg, and PaCO2 of 35 mmHg, indicating an improvement in her oxygenation status. While her condition is stabilizing, the healthcare team remains vigilant, monitoring for any signs of new complications such as vaso-occlusive crises or further respiratory issues. They also begin discussions on long-term management strategies, including hydroxyurea therapy, to prevent future sickle cell crises and enhance her quality of life.

Section 4

Two days following the initial interventions, the patient begins to exhibit signs of a new complication. She reports increased joint pain, particularly in her knees and elbows, accompanied by swelling and warmth in these areas. Her pain is rated at 8 out of 10, which is significantly higher than her baseline discomfort. The healthcare team suspects a vaso-occlusive crisis, a common complication in sickle cell anemia, where sickled red blood cells obstruct capillaries and restrict blood flow to various organs and tissues.

Further diagnostic work-up reveals an elevated lactate dehydrogenase (LDH) level at 350 U/L, indicating increased hemolysis, and a reticulocyte count of 12%, suggesting a compensatory response of the bone marrow to anemia. The patient's hemoglobin level remains unchanged at 7.5 g/dL, despite the recent transfusion, which prompts the team to consider additional transfusion therapy. Meanwhile, her vital signs show a slight increase in her heart rate to 105 bpm and a low-grade fever of 100.4°F, further supporting the diagnosis of a vaso-occlusive event.

In response to these findings, the healthcare team initiates a comprehensive pain management protocol, including intravenous hydration and opioid analgesics, to relieve the acute pain and improve circulation. They continue to monitor her closely for any signs of acute organ dysfunction, such as renal impairment or acute chest syndrome recurrence, and discuss the potential need for exchange transfusion if her symptoms do not improve. Additionally, patient education on recognizing early symptoms of vaso-occlusive crises and adherence to long-term management plans, such as hydroxyurea therapy, becomes a priority to reduce future crisis frequency and improve her overall quality of life.

Section 5

As the team continues their efforts to manage the patient's vaso-occlusive crisis, they observe a change in the patient's status that warrants further attention. Despite the implementation of the comprehensive pain management protocol, the patient reports that her pain remains severe, with a persistent rating of 8 out of 10. Moreover, she now experiences difficulty breathing, characterized by a persistent cough and mild wheezing. Her oxygen saturation has decreased to 92% on room air, prompting the healthcare providers to supply supplemental oxygen and consider the possibility of acute chest syndrome, a serious complication in sickle cell anemia.

Further diagnostic imaging is ordered, including a chest X-ray, which reveals a new infiltrate in the right lower lobe of the lung, consistent with acute chest syndrome. Blood cultures are drawn to rule out an infectious process, and prophylactic antibiotics are initiated as a precautionary measure. Additionally, the healthcare team notes that the patient's white blood cell count has increased to 15,000/mm³, suggesting an inflammatory response, which could be contributing to her current respiratory symptoms.

In response to these evolving clinical findings, the decision is made to proceed with an urgent exchange transfusion to rapidly decrease the proportion of sickled cells and improve oxygenation. The goal is to alleviate the acute symptoms and prevent further complications. The patient is closely monitored for any adverse reactions to the transfusion and the healthcare team engages in a multidisciplinary discussion to reassess her long-term management strategy, emphasizing the importance of hydroxyurea therapy and regular follow-up to reduce the risk of future vaso-occlusive episodes and improve her overall prognosis.